Alliance Wealth Advisors (Utah)’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,171
Closed -$231K 261
2024
Q3
$231K Sell
1,171
-10
-0.8% -$2.08K 0.06% 225
2024
Q2
$244K Sell
1,181
-40
-3% -$9.06K 0.07% 207
2024
Q1
$331K Sell
1,221
-44
-3% -$10.5K 0.1% 191
2023
Q4
$299K Sell
1,265
-26
-2% -$5.11K 0.1% 193
2023
Q3
$253K Buy
1,291
+1
+0.1% +$205 0.09% 194
2023
Q2
$271K Buy
1,290
+2
+0.2% +$398 0.1% 188
2023
Q1
$260K Buy
1,288
+52
+4% +$11.8K 0.1% 194
2022
Q4
$269K Buy
+1,236
New +$270K 0.12% 172

Other funds holding CRL